Attenuation of proteolysis‐mediated cyclin E regulation by alternatively spliced Parkin in human colorectal cancers
Open Access
- 11 May 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 125 (9), 2029-2035
- https://doi.org/10.1002/ijc.24565
Abstract
Parkin has a critical role in the ubiquitin‐proteasome system as an E3‐ligase targeting several substrates. Our recent finding that Parkin‐deficient mice are susceptible to tumorigenesis provided evidence that Parkin is a tumor suppressor gene. Dysfunction of the Parkin gene is frequently observed in various human cancers, but the mechanism underlying the cell cycle disruption induced by Parkin dysfunction that leads to carcinogenesis is not known. Here, we demonstrated that Parkin expression in colonic epithelial cells is regulated in a cell cycle‐associated manner. Epidermal growth factor (EGF) stimulation upregulated Parkin gene expression in human colon cells. Inhibition of the phosphoinositide 3‐kinase [PI(3)K]‐Akt‐dependent pathways suppressed growth factor‐induced Parkin expression. The expression of alternatively spliced Parkin isoforms with various deletions spanning exons 3–6 was detected in 18 of 43 (42%) human colorectal cancer tissues. Wild‐type Parkin induced the degradation of cyclin E protein, but the alternatively spliced Parkin identified in colon cancers showed defective proteolysis of cyclin E. These findings indicate that Parkin expression is induced by growth factor stimulation and is involved in the cell cycle regulation of colon cells. Tumor‐specific expression of alternatively spliced Parkin isoforms might contribute to enhanced cell proliferation through the attenuation of proteolysis‐mediated cyclin E regulation in human colorectal cancers. © 2009 UICCFunding Information
- Grants-in-Aid for Scientific Research (8209027, 20012029, 20590774)
This publication has 39 references indexed in Scilit:
- Parkin as a tumor suppressor gene for hepatocellular carcinomaOncogene, 2008
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2006
- Aberrant and Alternative Splicing in CancerCancer Research, 2004
- Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates β-catenin activity in a p53-dependent mannerOncogene, 2004
- How do Parkin mutations result in neurodegeneration?Current Opinion in Neurobiology, 2004
- Tumor-Specific Low Molecular Weight Forms of Cyclin E Induce Genomic Instability and Resistance to p21, p27, and Antiestrogens in Breast CancerCancer Research, 2004
- Cyclin E deregulation alters the biologic properties of ovarian cancer cellsOncogene, 2004
- M6P/IGF2R is mutated in squamous cell carcinoma of the lungOncogene, 2000
- Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesisOncogene, 1999
- G1 phase progression: Cycling on cueCell, 1994